Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Perinatol. 2021 Nov 30;42(2):260–261. doi: 10.1038/s41372-021-01283-4

Table 1.

Participant characteristics and responses

Participant Characteristics (N=551)
Gender Female 62%
Male 38%
NICU Level Level II 3%
Level III 37%
Level IV 61%
Testing Practices Overall (N=551) Level II/III NICU (N=217) Level IV NICU (N=334)
Percentage of patients undergoing genetic testing < 5% 19% 39% 6%
5–10% 35% 35% 35%
11–25% 30% 19% 37%
26–50% 13% 6% 18%
>50% 3% 2% 4%
Clinical geneticist at institution No 19% 41% 5%
Yes 81% 59% 96%
Standardized criteria for which patients undergo genetic testing No 71% 77% 66%
Yes 17% 11% 21%
Not sure 13% 12% 13%
Approval from genetics for sending some types of genetic tests No 46% 54% 41%
Yes 45% 38% 50%
Not sure 9% 8% 9%
Ability to send rapid whole exome sequencing (return of results <1 month) No 16% 22% 12%
Yes 63% 51% 71%
Not sure 21% 27% 17%
Counseling Practices Overall (N=551) Level II/III NICU (N=217) Level IV NICU (N=334)
What steps do you take to educate a family and seek consent before sending genetic sequencing tests?
Genetics team usually meets with the family before sending the test 58% 43% 68%
Neonatology team usually discusses the test with the family 81% 87% 78%
Provide written information about genetic testing 29% 34% 26%
Get written consent from the family before sending the testing 30% 4% 33%
In your institution, are medical providers from the following disciplines responsible for disclosing genetic results to parents?
Neonatologists 95% 98% 93%
Geneticists 81% 64% 92%
Genetic Counselors 61% 45% 71%
Neurologists 48% 43% 51%
Other 10% 9% 10%